Bevacizumab for Breast Cancer: Scientific Evidence Versus Real World Data (RWD) in Brazil

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.2611
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Real World Data (Rwd) at T=4 in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Report on the Current Status of the Use of Real‐world Data (RWD) and Real‐world Evidence (RWE) in Drug Development and Regulation

British Journal of Clinical Pharmacology
Pharmacology
2019English

Guy’s Cancer Cohort – Real World Evidence for Cancer Pathways

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Palbociclib in Metastatic Breast Cancer: Current Evidence and Real-Life Data

Drugs in Context
Molecular MedicinePharmacology
2019English

Pcp53 - A Diagnostic Framework to Evaluate Real-World Data Sources for Real-World Evidence Generation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Therapy Landscape in Patients With Metastatic HER2-Positive Breast Cancer: Data From the PRAEGNANT Real-World Breast Cancer Registry

Cancers
Cancer ResearchOncology
2018English

Real-World Evidence Research Based on Big Data

Onkologe
OncologyHematology
2018English

Fulfilling the Potential of Real-World Evidence for Lung Cancer in Canada

Current Oncology
Oncology
2019English

P1.15-03 Clinical Characteristics of Long-Term Survivors With Nivolumab in Pretreated Advanced NSCLC From Real-World Data (RWD)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy